Cargando…

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study

BACKGROUND: Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. OBJECTIVE: The objective was to evaluate current and identify additional clinical factors that are linked to long term outcome of relapsing-remitting MS assessed by disability s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Ehling, Rainer, Lutterotti, Andreas, Hegen, Harald, Di Pauli, Franziska, Auer, Michael, Deisenhammer, Florian, Reindl, Markus, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938610/
https://www.ncbi.nlm.nih.gov/pubmed/27391947
http://dx.doi.org/10.1371/journal.pone.0158978
_version_ 1782441890331754496
author Bsteh, Gabriel
Ehling, Rainer
Lutterotti, Andreas
Hegen, Harald
Di Pauli, Franziska
Auer, Michael
Deisenhammer, Florian
Reindl, Markus
Berger, Thomas
author_facet Bsteh, Gabriel
Ehling, Rainer
Lutterotti, Andreas
Hegen, Harald
Di Pauli, Franziska
Auer, Michael
Deisenhammer, Florian
Reindl, Markus
Berger, Thomas
author_sort Bsteh, Gabriel
collection PubMed
description BACKGROUND: Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. OBJECTIVE: The objective was to evaluate current and identify additional clinical factors that are linked to long term outcome of relapsing-remitting MS assessed by disability status 10 years after disease onset. METHODS: This observational study included 793 patients with relapsing-remitting MS. Clinical factors hypothesized to influence long term outcome measured by EDSS scores 10 years after disease onset were analysed by Kaplan-Meier-estimates. Multinomial logistic regression models regarding mild (EDSS ≤2.5), moderate (EDSS 3.0–5.5) or severe (EDSS ≥6.0) disability were calculated to correct for confounders. RESULTS: Secondary progression was the strongest predictor of severe disability (Hazard ratio [HR] 503.8, 95% confidence interval [CI] 160.0–1580.1); p<0.001). Complete remission of neurological symptoms at onset reduced the risk of moderate disability (HR 0.42; CI 0.23–0.77; p = 0.005), while depression (HR 3.59; CI 1.14–11.24; p = 0.028) and cognitive dysfunction (HR 4.64; CI 1.11–19.50; p = 0.036) 10 years after disease onset were associated with severe disability. Oligoclonal bands and pregnancy were not correlated with disability. CONCLUSION: We were able to identify clinically apparent chronic depression and cognitive dysfunction to be associated with adverse long term outcome in MS and to confirm that pregnancy has no negative impact. Additionally, we emphasize the positive predictive value of complete remission of initial symptoms.
format Online
Article
Text
id pubmed-4938610
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49386102016-07-22 Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study Bsteh, Gabriel Ehling, Rainer Lutterotti, Andreas Hegen, Harald Di Pauli, Franziska Auer, Michael Deisenhammer, Florian Reindl, Markus Berger, Thomas PLoS One Research Article BACKGROUND: Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. OBJECTIVE: The objective was to evaluate current and identify additional clinical factors that are linked to long term outcome of relapsing-remitting MS assessed by disability status 10 years after disease onset. METHODS: This observational study included 793 patients with relapsing-remitting MS. Clinical factors hypothesized to influence long term outcome measured by EDSS scores 10 years after disease onset were analysed by Kaplan-Meier-estimates. Multinomial logistic regression models regarding mild (EDSS ≤2.5), moderate (EDSS 3.0–5.5) or severe (EDSS ≥6.0) disability were calculated to correct for confounders. RESULTS: Secondary progression was the strongest predictor of severe disability (Hazard ratio [HR] 503.8, 95% confidence interval [CI] 160.0–1580.1); p<0.001). Complete remission of neurological symptoms at onset reduced the risk of moderate disability (HR 0.42; CI 0.23–0.77; p = 0.005), while depression (HR 3.59; CI 1.14–11.24; p = 0.028) and cognitive dysfunction (HR 4.64; CI 1.11–19.50; p = 0.036) 10 years after disease onset were associated with severe disability. Oligoclonal bands and pregnancy were not correlated with disability. CONCLUSION: We were able to identify clinically apparent chronic depression and cognitive dysfunction to be associated with adverse long term outcome in MS and to confirm that pregnancy has no negative impact. Additionally, we emphasize the positive predictive value of complete remission of initial symptoms. Public Library of Science 2016-07-08 /pmc/articles/PMC4938610/ /pubmed/27391947 http://dx.doi.org/10.1371/journal.pone.0158978 Text en © 2016 Bsteh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bsteh, Gabriel
Ehling, Rainer
Lutterotti, Andreas
Hegen, Harald
Di Pauli, Franziska
Auer, Michael
Deisenhammer, Florian
Reindl, Markus
Berger, Thomas
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title_full Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title_fullStr Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title_full_unstemmed Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title_short Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
title_sort long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938610/
https://www.ncbi.nlm.nih.gov/pubmed/27391947
http://dx.doi.org/10.1371/journal.pone.0158978
work_keys_str_mv AT bstehgabriel longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT ehlingrainer longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT lutterottiandreas longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT hegenharald longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT dipaulifranziska longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT auermichael longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT deisenhammerflorian longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT reindlmarkus longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy
AT bergerthomas longtermclinicalprognosticfactorsinrelapsingremittingmultiplesclerosisinsightsfroma10yearobservationalstudy